Literature DB >> 27115572

Does the Term "Deflators" Reflect More Accurately the Beneficial Effects of Long-acting Bronchodilators in COPD?

Konstantinos Kostikas1,2, Nikolaos M Siafakas3.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27115572     DOI： 10.3109/15412555.2016.1153615

Source DB:  PubMed          Journal:  COPD        ISSN： 1541-2563            Impact factor:   2.409


× No keyword cloud information.
  5 in total

Review 1.  Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD.

Authors:  Anthony D D'Urzo; Peter Kardos; Russell Wiseman
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-04-04

2.  Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD-a randomised controlled study.

Authors:  Joerg Salomon; Daiana Stolz; Guido Domenighetti; Jean-Georges Frey; Alexander J Turk; Andrea Azzola; Thomas Sigrist; Jean-William Fitting; Ulrich Schmidt; Thomas Geiser; Corinne Wild; Konstantinos Kostikas; Andreas Clemens; Martin Brutsche
Journal:  Respir Res       Date:  2017-01-11

3.  Efficacy and safety of direct switch to indacaterol/glycopyrronium in patients with moderate COPD: the CRYSTAL open-label randomised trial.

Authors:  Claus F Vogelmeier; Mina Gaga; Maryam Aalamian-Mattheis; Timm Greulich; Jose M Marin; Walter Castellani; Vincent Ninane; Stephen Lane; Xavier Nunez; Francesco Patalano; Andreas Clemens; Konstantinos Kostikas
Journal:  Respir Res       Date:  2017-07-18

4.  Indacaterol/glycopyrronium reduces the risk of clinically important deterioration after direct switch from baseline therapies in patients with moderate COPD: a post hoc analysis of the CRYSTAL study.

Authors:  Claus F Vogelmeier; Andreas Clemens; Timm Greulich; Konstantinos Kostikas; Mina Gaga; Maryam Aalamian-Mattheis; Nadine S Lossi; Francesco Patalano; Xavier Nunez; Veronica A Pagano; Robert Fogel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-04-16

5.  Regional lung deflation with increased airway volume underlies the functional response to bronchodilators in chronic obstructive pulmonary disease.

Authors:  Naoya Tanabe; Susumu Sato; Shigeo Muro; Hiroshi Shima; Tsuyoshi Oguma; Kazuya Tanimura; Atsuyasu Sato; Toyohiro Hirai
Journal:  Physiol Rep       Date:  2019-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.